Nomogram Development for Assessing Oncotype <scp>DX</scp> Recurrence Scores in Breast Cancer: A Chinese Population Study

We present the first nomogram for predicting the RS in Chinese patients with BC on the basis of clinicopathological factors. This model could aid in identifying patients who may not need ODX testing and serve as a cost-effective alternative for those unable to access ODX, thereby optimizing treatment decisions and enhancing patient management in resource-limited settings.